Eruptive melanocytic nevi with malignant transformations and the connection to BRAF and p16 mutations  by Yang, Ting-Hua et al.
lable at ScienceDirect
DERMATOLOGICA SINICA 35 (2017) 30e33Contents lists avaiDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comCASE REPORTEruptive melanocytic nevi with malignant transformations and the
connection to BRAF and p16 mutations
Ting-Hua Yang 1, Kuo-Hsien Wang 1, 2, Hsiou-Hsin Tsai 1, 2, *, Jan-Show Chu 3, 4, *
1 Department of Dermatology, Taipei Medical University Hospital, Taipei, Taiwan
2 Department of Dermatology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
3 Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
4 Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwana r t i c l e i n f o
Article history:
Received: Nov 29, 2015
Revised: Mar 24, 2016





melanocytic tumor of uncertain malignant
potential
p16Conﬂicts of interest: The authors declare that the
ﬁnancial conﬂicts of interest related to the subject m
in this article.
* Corresponding authors. Taipei Medical Universit
11031, Taiwan.
E-mail addresses: tsaihh2000@yahoo.com.tw (H
(J.-S. Chu).
http://dx.doi.org/10.1016/j.dsi.2016.05.001
1027-8117/Copyright © 2016, Taiwanese Dermatologic
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Eruptive melanocytic nevi (EMN) is a rare phenomenon with an unclear pathogenesis. Mutation on a
molecular basis has been proposed, but insufﬁcient data are available to conﬁrm this hypothesis.
Theoretically, the possibility of malignant transformation is high, but no previous deﬁnite cases had been
reported. Herein, we report the ﬁrst case of a patient with EMN in whom hypopharyngeal low-grade
melanocytic malignancies were detected using a ﬁbrolaryngoscope. BRAF activation and p16 muta-
tions were discovered through real-time polymerase chain reaction and immunohistochemical staining
on EMN tissue samples, respectively. The signiﬁcance of these ﬁndings has yet to be determined.
Copyright © 2016, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Eruptive melanocytic nevi (EMN) is a rare phenomenon in which
hundreds of melanocytic nevi appear suddenly. This condition has
been associated with multiple dermatological diseases and sup-
pression of the immune system.1 Although EMN is associated with
a higher risk of malignant transformation, no previous study has
reported a concurrent melanocytic malignancy. BRAF and p16
mutations have been implicated in the pathogenesis of EMN,2,3 but
few studies have examined samples of EMN for these markers.
Herein, we report a rare case of EMN associated with multiple
concurrent low-grade melanocytic malignancies, for which we
performed an immunohistochemistry (IHC) study for p16 mutation
and used real-time polymerase chain reaction (PCR) to identify
BRAF mutation in tissue samples of EMN.y have no ﬁnancial or non-
atter or materials discussed
y, 250 Wuxing Street, Taipei
.-H. Tsai), jschu@tmu.edu.tw
al Association. Published by ElseviCase Report
A 32-year-old man presented with multiple asymptomatic purplish
and blackish papules (1e4 mm in diameter) over his trunk, axilla,
and upper extremities (Figures 1A and 1B). There were more than
100 of these lesions, all of which had abruptly erupted in the 6
months prior to the visit. Other skin ﬁndings and symptoms were
unremarkable. The patient was previously healthy and denied any
history of drug use. A skin biopsy was performed on one of the
lesions on his right abdomen. Microscopic examination revealed
that it was a Spitz nevus (Figures 1C and 1D). Under the impression
of EMN, we arranged a thorough examination. Two additional skin
biopsies were performed on lesions on the left abdomen and right
wrist, both of which were proven histopathologically to also be
Spitz nevi. His serum biochemical and hematologic panels were all
within normal limits, as were his levels of prostate-speciﬁc antigen,
cortisol, and adrenocorticotropic hormone. An anti-HIV antibody
test was negative. Chest radiography, panendoscopy, colonoscopy,
whole-body computed tomographic scan, and positron emission
tomography scan were all normal. However, ﬁbrolaryngoscopy
detected a pigmented lesion over the hypopharynx (Figure 2A),
which was then removed through laryngomicrosurgery. The tissue
was sent for pathology, which revealed a heavily pigmented papule
conﬁned to a superﬁcial connective tissue composed ofer Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Figure 1 (A) Numerous erupted melanocytic nevi in a 32-year-old man. (B) Close-up view of abdominal region. Nevi are 1e4 mm in diameter, mildly dome-shaped, and blackish. (C)
Microscopically, the lesion demonstrates features of a Spitz nevus, including a compound structure with a well-circumscribed outline, and heavy pigmentation (hematoxylin and
eosin 40). (D) High-power view showing large epithelioid and spindle nevus cell aggregation. (hematoxylin and eosin 100).
Figure 2 (A) A pigmented lesion detected under a ﬁbrolaryngoscope over the hypopharynx. Three newly erupted pigmented lesions are detected 1 month later in the same region
(not shown). (B) Histologic examination of the hypopharyngeal lesion reveals well-demarcated but slightly asymmetrical proliferation with heavy pigmentation under the scanning
view (hematoxylin and eosin 40). (C) Frequent pagetoid spread of nevus cells, singly and in nests are noted, they even located in the upper half of the epithelium (hematoxylin and
eosin 200) (D) Close-up view: the lesion is composed of conﬂuent large epithelioid nevus cells. The cells show mild pleomorphism and nuclear atypia. No mitotic ﬁgures or
atypical mitosis are detected throughout the lesion (hematoxylin and eosin 400).
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eosinophilic nucleoli, focal hyperchromatism and mild nuclear
atypia (Figure 2BeD). The lesion revealed both benign character-
istics, including a well-circumscribed architecture with maturation
and no mitotic activity, and troubling characteristics, including a
slightly asymmetrical architecture, conﬂuent cell nests, and
frequent pagetoid extensions of the nevus cell into the surface
epithelium, even in the upper half of the epithelium. These histo-
logic features led to a diagnosis of melanocytic tumor withuncertain malignant potential (MELTUMP). After 1 month, the pa-
tient returned for follow-up. The number of skin lesions had
increased and some of them had becomemore raised and enlarged.
He received a ﬁbrolaryngoscopy again, and three newly erupted
pigmented nevi were detected over the hypopharynx. All of them
were excised, sent for pathology, and proven histologically to be
MELTUMPs. We detected BRAF V600E mutations by using a real-
time melting curve analysis of PCR on four of the excised tissues
and using IHC to identify p16 in ﬁve of the excised tissues. The PCR
Figure 3 (A) Immunohistochemistry (IHC) staining for p16 performed on the excised cutaneous Spitz nevus of the right abdomen. In the scanning view, there is no signiﬁcant
staining with p16. As we used 3-amino-9-ethylcarbazole as chromogen to develop the reactions, the color of the p16 staining should be red. The brown color in the section thus
represents melanin pigment (p16 stain 100). (B) Close-up view showing very weak or negative p16 expression mixed with melanin pigment (p16 stain 400). (C) IHC staining for
p16 performed on the excised cutaneous Spitz nevus of the left abdomen. The nevus cells exhibit an extremely low percentage of positivity (p16 stain 100). (D) IHC staining for p16
performed on one of the excised hypopharyngeal MELTUMPs. In the scanning view, the melanocytic cells express diffuse positivity on the left side of the ﬁeld. An abrupt loss of p16
positivity on the right side is noted (p16 stain 40). (E) Close-up view of the right side of the ﬁeld demonstrating only scattering p16 expression in the melanocytic cells (p16 stain
400). (F) Another hypopharyngeal MELTUMP showing very weak or negative p16 positivity (p16 stain 100).
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the four excised tissues(Supplementary Table 1). The IHC staining
for the p16 revealed variable decreased positivity in all the ﬁve
excised samples, namely two cutaneous Spitz nevi and three
hypopharyngeal MELTUMPs (Figure 3). The sites of the excised le-
sions and corresponding examination results are shown in Table 1.
After complete staging, no lymph node or distant metastasis
was detected, thus, the treatment plan was mainly observation. On
the basis of the MELTUMP diagnosis, we arranged an intense
follow-up plan for the patient according to the guideline for ma-
lignant melanoma, including a thorough skin examination for
additional peculiar lesions, palpation of lymph nodes, and ﬁbro-
laryngoscopy, with particular attention paid to the hypopharynx
every 3months. The number of the nevus stopped increasing 1 year
after the initial eruption, but there was no sign of spontaneous
regression. During the subsequent 6 months of follow-up after the
removal of the hypopharyngeal MELTUMPs, there was no newly
detected melanocytic malignancy.
Discussion
EMN is a rare phenomenon in which hundreds of melanocytic nevi
appear suddenly.1 The lesions of EMN can include banal nevi, blue
nevi, and Spitz nevi.4 EMNmay arise in the setting of blistering skin
disease, immunosuppression, cytokine administration, biologicalTable 1 Excision site, pathologic diagnosis, and corresponding examination result.
Site Pathology BRAF mutation Percentage of p16
positive cells
Right abdomen Spitz nevus Present < 5% (Figures 3A & 3B)
Left wrist Spitz nevus Absent Test not performed
Left abdomen Spitz nevus Test not performed < 5% (Figure 3C)
Hypopharynx MELTUMP Present 50e60% (Figures 3D & 3E)
Hypopharynx MELTUMP Test not performed Test not performed
Hypopharynx MELTUMP Present < 5% (Figure 3F)
Hypopharynx MELTUMP Test not performed < 5% (Supplmentary Figure 1)
MELTUMP¼melanocytic tumor with uncertain malignant potential.agent administration, chemotherapy,1 Addison disease,5 paraneo-
plastic phenomena,6 pregnancy, and idiopathic causes.1,7 The pro-
posed pathogenesis of EMN includes diminished immune
surveillance, genetic susceptibility, and drug adverse effects,1
although the exact pathogenesis is not clearly understood. The
chance of potential malignant transformation is assumed to be
theoretically higher in patients with EMN. Regular screenings for
dysplastic nevi or melanoma have been recommended by many
authors.1e6 However, to our knowledge, no melanocytic malig-
nancy has been reported following an EMN eruption in the English-
language literature.
The concept of a MELTUMP was ﬁrst proposed in 2004 as
“borderline” melanocytic lesions that are difﬁcult for dermatopa-
thologists to classify as malignant or benign because of their
ambiguous morphology.8 In the present case, the pathology of the
hypopharyngeal lesions exhibited both benign characteristics
(well-circumscribed architecture with maturation and no mitotic
activity) and also troubling characteristics (a slightly asymmetrical
architecture, conﬂuent cell nests, and frequent pagetoid spread
even in the upper half of the epithelium). These lesions could not be
classiﬁed as merely benign nevi, but they also failed to meet the
criteria for melanoma, which is a constellation of multiple atypical
ﬁndings. Through consultations with dermatopathologists in
Taiwan, we concluded that the optimal diagnosis for these lesions is
a MELTUMP.
Two recent large case series of MELTUMPs have reported a low
risk of nodal metastasis (6e15%) and mortality from distant
metastasis during follow-up (1%).9,10 These results suggest that a
MELTUMP is a low-grade malignant melanocytic tumor and should
be treated according to the guidelines for invasive melanoma.9,10
We performed a careful workup but could not identify any
possible underlying diseases or medications related to EMN in this
patient. Indeed, most of the cases of EMN have been associated
with underlying diseases or medications,1,5,6 of which the disease
courses ﬂare and abate in parallel with the activity of the under-
lying diseases. However, as in the present case, a few cases of EMN
have been reported as being idiopathic, of these cases, the
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or lacking.1,7 These idiopathic cases further highlights the impor-
tance of investigating the molecular mechanisms underlying the
development of EMN. Sekulic et al2 proposed that the presence of
an activating BRAF mutation may play a role in the genesis of EMN
because of the ﬁnding that a BRAF V600E mutation was identiﬁed
in 85% of 20 examined EMN lesions. In another study, however,
BRAF V600E mutations were also found in > 80% of benign nevi.11
This apparent paradox was resolved by the discovery that most
nevi display the hallmarks of senescence and stain highly for the
tumor suppressor p16.3,12 P16 is a tumor suppressor that inhibits
the proliferation of cells through the G1 phase of the cell cycle. A
normal-functioned p16may lead to growth arrest in nevi harboring
BRAF V600E mutations. Thus, a p16 mutation may lead to bursts of
cell proliferation and has been implicated in the melanogenesis of
EMN, especially in those harboring BRAF V600E mutations.3
In previous studies, p16 stains for cutaneous or mucosal benign
nevi expressed a consistent pattern of diffuse positivity.13e15 Unlike
in previous studies,13e15 all the cutaneous Spitz nevi and hypo-
pharyngeal MELTUMPs in this case showed considerably decreased
percentages of p16 positivity, indicating an underlying aberration
of normal senescence pathway.
According to our preliminary results, this is the ﬁrst study to
demonstrate both BRAF and p16mutation in the same excised EMN
tissue, whether these mutations play a combined role in the initi-
ation and subsequent melanogenesis of EMN remains unknown.
Because of the limited number of EMN cases, large-scale studies are
warranted to establish the consistency of these ﬁndings. We hope
that these ﬁndings can contribute to future studies and treatment
options for EMN.
In conclusion, this is the ﬁrst case of EMN found to have con-
current melanocytic malignancies. We suggest thorough and
careful examinations and intense follow-up for patients with EMN,
and that ﬁbrolaryngoscopy should always be used as part of the
tumor work-up. The BRAF V600E and p16 mutations were specu-
lated in the excised EMN tissues, the signiﬁcance of which has yet
to be determined.References
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